
EU regulator to issue advice on Johnson & Johnson COVID-19 vaccine
Fox News
Experts at the European Medicines Agency are preparing to present Tuesday the conclusions of their investigation into possible links between the J&J COVID-19 vaccine and very rare cases of unusual clotting disorders detected in the U.S.
Johnson & Johnson advised European governments to store their doses until the EU drug regulator issued guidance on their use; widespread use of the shot in Europe has not yet started. The delay was a further blow to vaccination efforts in the European Union, which have been plagued by supply shortages, logistical problems and concerns over unusual blood clots also in a small number of people who received the AstraZeneca COVID-19 vaccine. Experts worry the temporary halt on J&J's shot could further shake vaccine confidence and complicate worldwide COVID-19 immunization efforts.More Related News